Lumen Technologies, Inc. (FRA:CYTH)

Lumen Technologies Statistics

Total Valuation

FRA:CYTH has a market cap or net worth of EUR 7.31 billion. The enterprise value is 20.68 billion.

Market Cap	7.31B
Enterprise Value	20.68B

Important Dates

The next estimated earnings date is Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	1.03B
Shares Outstanding	n/a
Shares Change (YoY)	+0.68%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	7.87%
Owned by Institutions (%)	67.56%
Float	944.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.68
PB Ratio	-7.32
P/TBV Ratio	n/a
P/FCF Ratio	7.00
P/OCF Ratio	1.76
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.14, with an EV/FCF ratio of 19.80.

EV / Earnings	-14.69
EV / Sales	1.89
EV / EBITDA	7.14
EV / EBIT	193.92
EV / FCF	19.80

Financial Position

The company has a current ratio of 2.21

Current Ratio	2.21
Quick Ratio	1.05
Debt / Equity	n/a
Debt / EBITDA	5.33
Debt / FCF	14.64
Interest Coverage	0.09

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	0.23%
Return on Invested Capital (ROIC)	0.43%
Return on Capital Employed (ROCE)	0.41%
Revenue Per Employee	450,654
Profits Per Employee	-58,667
Employee Count	25,000
Asset Turnover	0.37
Inventory Turnover	39.98

Taxes

Income Tax	-574.45M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.70% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-0.70%
50-Day Moving Average	6.81
200-Day Moving Average	4.58
Relative Strength Index (RSI)	47.20
Average Volume (20 Days)	4,302

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.89

Income Statement

In the last 12 months, FRA:CYTH had revenue of EUR 10.82 billion and -1.41 billion in losses. Loss per share was -1.43.

Revenue	10.82B
Gross Profit	5.09B
Operating Income	105.69M
Pretax Income	-1.98B
Net Income	-1.41B
EBITDA	2.52B
EBIT	105.69M
Loss Per Share	-1.43

Balance Sheet

The company has 2.05 billion in cash and 15.29 billion in debt, giving a net cash position of -13.25 billion.

Cash & Cash Equivalents	2.05B
Total Debt	15.29B
Net Cash	-13.25B
Net Cash Per Share	n/a
Equity (Book Value)	-999.75M
Book Value Per Share	-0.97
Working Capital	4.07B

Cash Flow

In the last 12 months, operating cash flow was 4.15 billion and capital expenditures -3.10 billion, giving a free cash flow of 1.04 billion.

Operating Cash Flow	4.15B
Capital Expenditures	-3.10B
Free Cash Flow	1.04B
FCF Per Share	n/a

Margins

Gross margin is 47.07%, with operating and profit margins of 0.98% and -13.02%.

Gross Margin	47.07%
Operating Margin	0.98%
Pretax Margin	-18.33%
Profit Margin	-13.02%
EBITDA Margin	23.30%
EBIT Margin	0.98%
FCF Margin	9.66%

Dividends & Yields

FRA:CYTH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.68%
Shareholder Yield	-0.68%
Earnings Yield	-19.25%
FCF Yield	14.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 1, 1999. It was a forward split with a ratio of 1.5.

Last Split Date	Apr 1, 1999
Split Type	Forward
Split Ratio	1.5

Scores

FRA:CYTH has an Altman Z-Score of -0.17 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.17
Piotroski F-Score	5